Mayo Clinic Laboratory and pathology research roundup: March 14 - Insights
This week's Research Roundup features: Novel through-the-scope suture closure of colonic Endoscopic Mucosal resection defects.
Education on this topic decreases misdiagnosis and the possibility of misinterpreting the comments provided by the reporting laboratories.
Inflammatory bowel disease - Insights
Our robust menu of inflammatory bowel disease (IBD) testing can assist with the diagnosis and management of IBD and includes first-line fecal testing for calprotectin; serologic analysis of clinically relevant antibodies; and genetic...
Precision mental and behavioral health therapeutics - Insights
Our Precision Mental and Behavioral Health Therapeutics initiative leverages cutting-edge diagnostic solutions to optimize medication management for psychiatric and neurologic patients.
Autoimmune Dementia Testing - Mayo Clinic Laboratories
Our phenotype specific testing for autoimmune dementia contains only clinically relevant antibodies providing accurate answers for treatment guidance.
Serotonin release assay - Insights
Find out more about our serotonin release assay, the gold standard diagnostic test for detecting heparin-induced thrombocytopenia antibodies.
Mayo Clinic Laboratory and pathology research roundup: June 6 - Insights
This week's research roundup feature: Utilizing mass spectrometry to detect and isotype monoclonal proteins in urine: Comparison to electrophoretic methods.
Mayo Clinic Laboratory and pathology research roundup: August 15 - Insights
This week's research roundup feature: Gain-of-function mutant p53 together with ERG proto-oncogene drive prostate cancer by beta-catenin activation and pyrimidine synthesis.
Mayo Clinic Laboratory and pathology research roundup: August 22 - Insights
This week's research roundup feature: Association of plasma biomarkers of Alzheimer Disease with cognition and medical comorbidities in a biracial cohort.
Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) calculator - Insights
For guidance on when to use the calculator, please see the following algorithm: Acquired Neuropathy Diagnostic Algorithm.
CPT codes and LOINC update: February 2023 - Insights
This page shows updates posted to Mayo Clinic Labs during the month of February.
Mayo Clinic Laboratory and Pathology Research Roundup: Dec. 25 - Insights
This week’s Research Roundup highlights global pulmonary vascular remodeling in pulmonary hypertension associated with heart failure and preserved or reduced ejection fraction.
CPT codes and LOINC update: April 2021 - Insights
The following list includes updates posted to mayocliniclabs.com during the month of April.
Mayo Clinic Laboratory and pathology research roundup: June 21 - Insights
Featured Abstract: A dynamic 3-factor survival model for acute myeloid leukemia that accounts for response to induction chemotherapy.
Mayo Clinic Laboratory and pathology research roundup: January 24 - Insights
This weeks research roundup features: Automated scoring of total inflammation in renal allograft biopsies
Assay stratifies pregnant women's preeclampsia risk: Joshua Bornhorst, Ph.D. - Insights
Joshua Bornhorst, Ph.D., explains how Mayo Clinic Laboratories' unique assay identifies pregnant women at risk of developing preeclampsia with severe features. Test results can guide clinical management, to safeguard maternal and neonatal...
Axonal autoimmune neuropathies - Insights
Find out about our panel-based approach to axonal autoimmune neuropathies, which we recommend because of the overlap in clinical symptoms.
The diagnosis of Myeloproliferative Neoplasm (MPN) must include an integrated approach and combine the clinical findings with laboratory results. In our latest “Hot Topic,” Rong He, M.D., discusses the subclassification of MPNs and the use...
Mayo Clinic Laboratory and Pathology Research Roundup: Sept. 17 - Insights
This week’s Research Roundup highlights the risk of MGUS in relatives of multiple myeloma cases by clinical and tumor characteristics.
Mayo Clinic Laboratory and Pathology Research Roundup: March 12 - Insights
This week's research roundup feature: C3 glomerulopathy (C3G) is a rare disease resulting from dysregulation of the alternative pathway of complement. C3G includes C3 glomerulonephritis (C3GN) and dense deposit disease (DDD), both of which...
Mayo Clinic Laboratory and pathology research roundup: September 26 - Insights
This week's research roundup feature: Semaglutide in HFpEF across obesity class and by body weight reduction.
Mayo Clinic Laboratory and pathology research roundup: September 27 - Insights
This week's research roundup features: Robotics in neurosurgery: current prevalence and future directions
Mayo Clinic Laboratory and Pathology Research Roundup: July 30 - Insights
This week’s Research Roundup highlights a randomized trial of spheroid reservoir bioartificial liver in Porcine model of post-hepatectomy liver failure.
CPT Codes and LOINC Update: May 2020 - Insights
View a full list of new CPT codes, Test Classification Updates, LOINC Codes, and Z-Codes posted to mayocliniclabs.com during the month of May.
Mayo Clinic Laboratories’ BioPharma Diagnostics team facilitates customized collaborations with diagnostic companies to support their clinical and research testing needs.
New tests launched in November - Insights
In November 2022, Mayo Clinic Laboratories announced eighteen new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
Assay enhances and simplifies M-proteins screening: David Murray, M.D., Ph.D. - Insights
David Murray, M.D., Ph.D., explains how Mayo Clinic Laboratories' MASS-FIX Quantitation assay provides next-generation screening for M-proteins, which are associated with multiple myeloma and other diseases. The assay better quantitates the...
Antibody against the GABA-A receptor is a biomarker of autoimmune encephalopathy that occurs across the lifespan, and disproportionately affects children. In this test-specific episode of the "Answers From the Lab" podcast, Andrew McKeon,...
New Panels Help Find Cause of Rapidly Progressive Dementia: Gregg Day, M.D. - Insights
Rapidly progressive dementia (RPD) is an umbrella term covering many devasting conditions, including Creutzfeldt-Jakob disease (CJD). Gregory (Gregg) Day, M.D., explains how Mayo Clinic Laboratories' unique RPD evaluation and new CJD test...
John Mills, Ph.D., and Divyanshu Dubey, M.B.B.S., explain how Mayo Clinic Laboratories' new test panel can distinguish among various potential causes of demyelinating neuropathies. Test results are important for managing these devastating...
Maria Alice Willrich, Ph.D., and Melissa Snyder, Ph.D., explain how Mayo Clinic Laboratories' unique risankizumab panel measures levels of both that drug and its antibodies in patients' blood. The results can better guide the management of...
search - Mayo Clinic Laboratories
Search Results Site Search...
search - Mayo Clinic Laboratories
Search Results Site Search...
The assay is now recommended for diagnosing and monitoring patients with monoclonal protein disorders and exclusively available through Mayo Clinic Laboratories– Rochester.
CPT codes and LOINC update: March 2023 - Insights
This page includes updates posted to Mayo Clinic Labs during the month of March.
Research Roundup Archives - Page 21 of 29 - Insights
Skip to Content MayoACCESS MayoLINK...
https://news.mayocliniclabs.com/file-autoimmune-neurology-test-ordering-guide/
N EURO LO GY START ORDERING TODAY. PUT YOUR PATIENTS ON THE PATH TO THE RIGHT ANSWER. CALL 800-533-1710 OR VISIT MAYOCLINICLABS.COM/CUSTOMER-SERVICE/CONTACTS. N EURO LO GY © 2024 Mayo Foundation for Medical Education and Research. All...
Mayo Clinic Laboratory and Pathology Research Roundup: April 10 - Insights
This week’s Research Roundup highlights thyroid hormone treatment among pregnant women with subclinical hypothyroidism.
Mayo Clinic Laboratory and Pathology Research Roundup: December 12 - Insights
This week's research roundup feature: Most patients with solitary bone plasmacytomas (SBP) progress to multiple myeloma (MM) after definitive radiation therapy as their primary treatment. Whether the presence of high-risk (HR) cytogenetic...
One Test, Multiple Targets: Zeroing in on Autoimmune Movement Disorders - Insights
A movement disorder might be caused by the body’s immune system, which is meant to fight infections, suddenly attacking the brain. Fortunately, an “autoimmune movement disorder” can often be treated—once its cause is discovered.
Mayo Clinic Laboratory and pathology research roundup: November 15 - Insights
This week's research roundup features: Renin production by juxtaglomerular cell tumors and clear cell renal cell carcinoma and the role of angiotensin signaling inhibitors
Mayo Clinic Laboratory and Pathology Research Roundup: June 19 - Insights
This week’s Research Roundup highlights the single-nephron glomerular filtration rate in healthy adults.
Mayo Clinic Laboratory and Pathology Research Roundup: July 17 - Insights
This week’s Research Roundup highlights postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease.
Research Archives - Page 24 of 33 - Insights
Skip to Content MayoACCESS MayoLINK...
Research Roundup Archives - Page 20 of 29 - Insights
Skip to Content MayoACCESS MayoLINK...
Mayo Clinic Laboratory and Pathology Research Roundup: Oct. 30 - Insights
This week’s Research Roundup highlights rates of hippocampal atrophy and presence of post-mortem TDP-43 in patients with Alzheimer's disease.
Mayo Clinic Laboratories cerebrospinal fluid metagenomic testing uses shotgun metagenomic sequencing to interrogate all microbial DNA and RNA present in a sample and determine the presence of potential pathogens.
Mucopolysaccharidosis - Insights
Learn more about how Mayo Clinic Laboratories’ testing for mucopolysaccharidosis can assist with diagnosis and disease management.
Including carrier screening, molecular testing, and cytogenetic analysis, Mayo Clinic Laboratories prenatal evaluations provide vital insights for prospective and expecting parents.
Learn more about how Mayo Clinic Laboratories’ targeted, high-resolution screening panel for stimulant use identifies and confirms the presence of 10 stimulants and phencyclidine (PCP) with a single test.